Trial · NCT04788511
Results by group40
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 40
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS) | Semaglutide 2.4 mg | 16.8 | Standard Deviation 17.9 | Score on a scale | |
| Change in Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS) | Placebo | 10.3 | Standard Deviation 17.3 | Score on a scale | |
| Change in Body Weight | Semaglutide 2.4 mg | -13.9 | Standard Deviation 8.1 | Percentage of body weight | |
| Change in Body Weight | Placebo | -2.5 | Standard Deviation 5.6 | Percentage of body weight | |
| Change in Six-minute Walking Distance (6MWD) | Semaglutide 2.4 mg | 23.5 | Standard Deviation 59.2 | Meters | |
| Change in Six-minute Walking Distance (6MWD) | Placebo | 5.8 | Standard Deviation 62.7 | Meters | |
| The Hierarchical Composite Endpoint: Percentage of Wins of Participant Pairs | Semaglutide 2.4 mg | 60.1 | Percentages of wins of participant pairs | ||
| The Hierarchical Composite Endpoint: Percentage of Wins of Participant Pairs | Placebo | 34.9 | Percentages of wins of participant pairs | ||
| Change in C-Reactive Protein (CRP): Ratio to Baseline | Semaglutide 2.4 mg | 0.55 | Geometric Coefficient of Variation 121.5 | Ratio of C-reactive protein | |
| Change in C-Reactive Protein (CRP): Ratio to Baseline | Placebo | 0.92 | Geometric Coefficient of Variation 105.3 | Ratio of C-reactive protein | |
| Percentage of Participants Achieving 10 Percent (%) Weight Loss (Yes/No) | Semaglutide 2.4 mg | No | 34.1 | Percentage of participants | |
| Percentage of Participants Achieving 10 Percent (%) Weight Loss (Yes/No) | Placebo | No | 90.5 | Percentage of participants | |
| Percentage of Participants Achieving 10 Percent (%) Weight Loss (Yes/No) | Semaglutide 2.4 mg | Yes | 65.9 | Percentage of participants | |
| Percentage of Participants Achieving 10 Percent (%) Weight Loss (Yes/No) | Placebo | Yes | 9.5 | Percentage of participants | |
| Percentage of Participants Achieving 15% Weight Loss (Yes/No) | Semaglutide 2.4 mg | No | 56.1 | Percentage of participants | |
| Percentage of Participants Achieving 15% Weight Loss (Yes/No) | Placebo | No | 97.9 | Percentage of participants | |
| Percentage of Participants Achieving 15% Weight Loss (Yes/No) | Semaglutide 2.4 mg | Yes | 43.9 | Percentage of participants | |
| Percentage of Participants Achieving 15% Weight Loss (Yes/No) | Placebo | Yes | 2.1 | Percentage of participants | |
| Percentage of Participants Achieving 20% Weight Loss (Yes/No) | Semaglutide 2.4 mg | No | 76.4 | Percentage of participants | |
| Percentage of Participants Achieving 20% Weight Loss (Yes/No) | Placebo | No | 99.6 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04788511/results